-
1
-
-
84879592480
-
Non-coding RNA: A novel opportunity for the personalized treatment of multiple myeloma
-
Amodio, N, Di Martino, MT, Neri, A, Tagliaferri, P and Tassone, P (2013). Non-coding RNA: a novel opportunity for the personalized treatment of multiple myeloma. Expert Opin Biol Ther 13 (SUPPL. 1): S125-S137.
-
(2013)
Expert Opin Biol Ther
, vol.13
, pp. S125-S137
-
-
Amodio, N.1
Di Martino, M.T.2
Neri, A.3
Tagliaferri, P.4
Tassone, P.5
-
2
-
-
81355142141
-
Non-coding RNAs in human disease
-
Esteller, M (2011). Non-coding RNAs in human disease. Nat Rev Genet 12: 861-874.
-
(2011)
Nat Rev Genet
, vol.12
, pp. 861-874
-
-
Esteller, M.1
-
3
-
-
12144290519
-
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
-
Calin, GA, Sevignani, C, Dumitru, CD, Hyslop, T, Noch, E, Yendamuri, S et al. (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101: 2999-3004.
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 2999-3004
-
-
Calin, G.A.1
Sevignani, C.2
Dumitru, C.D.3
Hyslop, T.4
Noch, E.5
Yendamuri, S.6
-
4
-
-
84928715671
-
The microRNA feedback regulation of p63 in cancer progression
-
Lin, C, Li, X, Zhang, Y, Guo, Y, Zhou, J, Gao, K et al. (2015). The microRNA feedback regulation of p63 in cancer progression. Oncotarget 6: 8434-8453.
-
(2015)
Oncotarget
, vol.6
, pp. 8434-8453
-
-
Lin, C.1
Li, X.2
Zhang, Y.3
Guo, Y.4
Zhou, J.5
Gao, K.6
-
5
-
-
84938885920
-
Integrated analysis of microRNAs, transcription factors and target genes expression discloses a specific molecular architecture of hyperdiploid multiple myeloma
-
Di Martino, MT, Guzzi, PH, Caracciolo, D, Agnelli, L, Neri, A, Walker, BA et al. (2015). Integrated analysis of microRNAs, transcription factors and target genes expression discloses a specific molecular architecture of hyperdiploid multiple myeloma. Oncotarget 6: 19132-19147.
-
(2015)
Oncotarget
, vol.6
, pp. 19132-19147
-
-
Di Martino, M.T.1
Guzzi, P.H.2
Caracciolo, D.3
Agnelli, L.4
Neri, A.5
Walker, B.A.6
-
6
-
-
84879476643
-
Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemia
-
Lionetti, M, Musto, P, Di Martino, MT, Fabris, S, Agnelli, L, Todoerti, K et al. (2013). Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemia. Clin Cancer Res 19: 3130-3142.
-
(2013)
Clin Cancer Res
, vol.19
, pp. 3130-3142
-
-
Lionetti, M.1
Musto, P.2
Di Martino, M.T.3
Fabris, S.4
Agnelli, L.5
Todoerti, K.6
-
7
-
-
84866410501
-
Promises and challenges of MicroRNA-based treatment of multiple myeloma
-
Tagliaferri, P, Rossi, M, Di Martino, MT, Amodio, N, Leone, E, Gulla, A et al. (2012). Promises and challenges of MicroRNA-based treatment of multiple myeloma. Curr Cancer Drug Targets 12: 838-846.
-
(2012)
Curr Cancer Drug Targets
, vol.12
, pp. 838-846
-
-
Tagliaferri, P.1
Rossi, M.2
Di Martino, M.T.3
Amodio, N.4
Leone, E.5
Gulla, A.6
-
8
-
-
84931088607
-
miR-29s: A family of epi-miRNAs with therapeutic implications in hematologic Malignancies
-
Amodio, N, Rossi, M, Raimondi, L, Pitari, MR, Botta, C, Tagliaferri, P et al. (2015). miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies. Oncotarget 6: 12837-12861.
-
(2015)
Oncotarget
, vol.6
, pp. 12837-12861
-
-
Amodio, N.1
Rossi, M.2
Raimondi, L.3
Pitari, M.R.4
Botta, C.5
Tagliaferri, P.6
-
9
-
-
84881349597
-
From target therapy to miRNA therapeutics of human multiple myeloma: Theoretical and technological issues in the evolving scenario
-
Rossi, M, Amodio, N, Di Martino, MT, Caracciolo, D, Tagliaferri, P and Tassone, P (2013). From target therapy to miRNA therapeutics of human multiple myeloma: theoretical and technological issues in the evolving scenario. Curr Drug Targets 14: 1144-1149.
-
(2013)
Curr Drug Targets
, vol.14
, pp. 1144-1149
-
-
Rossi, M.1
Amodio, N.2
Di Martino, M.T.3
Caracciolo, D.4
Tagliaferri, P.5
Tassone, P.6
-
10
-
-
84862185932
-
The therapeutic potential of microRNAs in cancer
-
Thorsen, SB, Obad, S, Jensen, NF, Stenvang, J and Kauppinen, S (2012). The therapeutic potential of microRNAs in cancer. Cancer J 18: 275-284.
-
(2012)
Cancer J
, vol.18
, pp. 275-284
-
-
Thorsen, S.B.1
Obad, S.2
Jensen, N.F.3
Stenvang, J.4
Kauppinen, S.5
-
11
-
-
84890290469
-
miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells
-
Amodio, N, Bellizzi, D, Leotta, M, Raimondi, L, Biamonte, L, D'Aquila, P et al. (2013). miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells. Cell Cycle 12: 3650-3662.
-
(2013)
Cell Cycle
, vol.12
, pp. 3650-3662
-
-
Amodio, N.1
Bellizzi, D.2
Leotta, M.3
Raimondi, L.4
Biamonte, L.5
D'Aquila, P.6
-
12
-
-
84896119502
-
In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells
-
Di Martino, MT, Gullà, A, Gallo Cantafio, ME, Altomare, E, Amodio, N, Leone, E et al. (2014). In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells. PLoS One 9: e89659.
-
(2014)
PLoS One
, vol.9
-
-
Di Martino, M.T.1
Gullà, A.2
Gallo Cantafio, M.E.3
Altomare, E.4
Amodio, N.5
Leone, E.6
-
13
-
-
84902085012
-
Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: In vitro and in vivo anti-tumor activity
-
Raimondi, L, Amodio, N, Di Martino, MT, Altomare, E, Leotta, M, Caracciolo, D et al. (2014). Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: In vitro and in vivo anti-tumor activity. Oncotarget 5: 3039-3054.
-
(2014)
Oncotarget
, vol.5
, pp. 3039-3054
-
-
Raimondi, L.1
Amodio, N.2
Di Martino, M.T.3
Altomare, E.4
Leotta, M.5
Caracciolo, D.6
-
14
-
-
84907171169
-
MicroRNA and multiple myeloma: From laboratory findings to translational therapeutic approaches
-
Rossi, M, Amodio, N, Di Martino, MT, Tagliaferri, P, Tassone, P and Cho, WC (2014). MicroRNA and multiple myeloma: from laboratory findings to translational therapeutic approaches. Curr Pharm Biotechnol 15: 459-467.
-
(2014)
Curr Pharm Biotechnol
, vol.15
, pp. 459-467
-
-
Rossi, M.1
Amodio, N.2
Di Martino, M.T.3
Tagliaferri, P.4
Tassone, P.5
Cho, W.C.6
-
15
-
-
84906691556
-
A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells
-
Leotta, M, Biamonte, L, Raimondi, L, Ronchetti, D, Di Martino, MT, Botta, C et al. (2014). A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells. J Cell Physiol 229: 2106-2116.
-
(2014)
J Cell Physiol
, vol.229
, pp. 2106-2116
-
-
Leotta, M.1
Biamonte, L.2
Raimondi, L.3
Ronchetti, D.4
Di Martino, M.T.5
Botta, C.6
-
16
-
-
84877100047
-
Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth
-
Leone, E, Morelli, E, Di Martino, MT, Amodio, N, Foresta, U, Gullà, A et al. (2013). Targeting miR-21 inhibits In vitro and in vivo multiple myeloma cell growth. Clin Cancer Res 19: 2096-2106.
-
(2013)
Clin Cancer Res
, vol.19
, pp. 2096-2106
-
-
Leone, E.1
Morelli, E.2
Di Martino, M.T.3
Amodio, N.4
Foresta, U.5
Gullà, A.6
-
17
-
-
84896134590
-
Transferrin-conjugated SNALPs encapsulating 2'-O-methylated miR-34a for the treatment of multiple myeloma
-
Scognamiglio, I, Di Martino, MT, Campani, V, Virgilio, A, Galeone, A, Gullà, A et al. (2014). Transferrin-conjugated SNALPs encapsulating 2'-O-methylated miR-34a for the treatment of multiple myeloma. Biomed Res Int 2014: 217-365.
-
(2014)
Biomed Res Int
, vol.2014
, pp. 217-365
-
-
Scognamiglio, I.1
Di Martino, M.T.2
Campani, V.3
Virgilio, A.4
Galeone, A.5
Gullà, A.6
-
18
-
-
84871694384
-
DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma
-
Amodio, N, Leotta, M, Bellizzi, D, Di Martino, MT, D'Aquila, P, Lionetti, M et al. (2012). DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma. Oncotarget 3: 1246-1258.
-
(2012)
Oncotarget
, vol.3
, pp. 1246-1258
-
-
Amodio, N.1
Leotta, M.2
Bellizzi, D.3
Di Martino, M.T.4
D'Aquila, P.5
Lionetti, M.6
-
19
-
-
84897872063
-
In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma
-
Di Martino, MT, Campani, V, Misso, G, Gallo Cantafio, ME, Gullà, A, Foresta, U et al. (2014). In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma. PLoS One 9: e90005.
-
(2014)
PLoS One
, vol.9
-
-
Di Martino, M.T.1
Campani, V.2
Misso, G.3
Gallo Cantafio, M.E.4
Gullà, A.5
Foresta, U.6
-
20
-
-
84875766140
-
In vitro and in vivo anti-tumor activity of miR-221/222 inhibitors in multiple myeloma
-
Di Martino, MT, Gullà, A, Cantafio, ME, Lionetti, M, Leone, E, Amodio, N et al. (2013). In vitro and in vivo anti-tumor activity of miR-221/222 inhibitors in multiple myeloma. Oncotarget 4: 242-255.
-
(2013)
Oncotarget
, vol.4
, pp. 242-255
-
-
Di Martino, M.T.1
Gullà, A.2
Cantafio, M.E.3
Lionetti, M.4
Leone, E.5
Amodio, N.6
-
21
-
-
84866434864
-
Mouse models as a translational platform for the development of new therapeutic agents in multiple myeloma
-
Tassone, P, Neri, P, Burger, R, Di Martino, MT, Leone, E, Amodio, N et al. (2012). Mouse models as a translational platform for the development of new therapeutic agents in multiple myeloma. Curr Cancer Drug Targets 12: 814-822.
-
(2012)
Curr Cancer Drug Targets
, vol.12
, pp. 814-822
-
-
Tassone, P.1
Neri, P.2
Burger, R.3
Di Martino, M.T.4
Leone, E.5
Amodio, N.6
-
22
-
-
84869219338
-
miR-34 - A microRNA replacement therapy is headed to the clinic
-
Bader, AG (2012). miR-34 - a microRNA replacement therapy is headed to the clinic. Front Genet 3: 120.
-
(2012)
Front Genet
, vol.3
, pp. 120
-
-
Bader, A.G.1
-
23
-
-
84870543762
-
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor sp1
-
Amodio, N, Di Martino, MT, Foresta, U, Leone, E, Lionetti, M, Leotta, M et al. (2012). miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1. Cell Death Dis 3: e436.
-
(2012)
Cell Death Dis
, vol.3
, pp. e436
-
-
Amodio, N.1
Di Martino, M.T.2
Foresta, U.3
Leone, E.4
Lionetti, M.5
Leotta, M.6
-
24
-
-
84869238270
-
Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: In vitro and in vivo evidence
-
Di Martino, MT, Leone, E, Amodio, N, Foresta, U, Lionetti, M, Pitari, MR et al. (2012). Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: In vitro and in vivo evidence. Clin Cancer Res 18: 6260-6270.
-
(2012)
Clin Cancer Res
, vol.18
, pp. 6260-6270
-
-
Di Martino, M.T.1
Leone, E.2
Amodio, N.3
Foresta, U.4
Lionetti, M.5
Pitari, M.R.6
-
25
-
-
84946494986
-
Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo
-
Morelli, E, Leone, E, Cantafio, ME, Di Martino, MT, Amodio, N, Biamonte, L et al. (2015). Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo. Leukemia 29: 2173-2183.
-
(2015)
Leukemia
, vol.29
, pp. 2173-2183
-
-
Morelli, E.1
Leone, E.2
Cantafio, M.E.3
Di Martino, M.T.4
Amodio, N.5
Biamonte, L.6
-
26
-
-
84931044088
-
miR-497 and miR-34a retard lung cancer growth by co-inhibiting cyclin E1 (CCNE1)
-
Han, Z, Zhang, Y, Yang, Q, Liu, B, Wu, J, Zhang, Y et al. (2015). miR-497 and miR-34a retard lung cancer growth by co-inhibiting cyclin E1 (CCNE1). Oncotarget 6: 13149-13163.
-
(2015)
Oncotarget
, vol.6
, pp. 13149-13163
-
-
Han, Z.1
Zhang, Y.2
Yang, Q.3
Liu, B.4
Wu, J.5
Zhang, Y.6
-
27
-
-
84940890937
-
Ectopic expression of miR-494 inhibited the proliferation, invasion and chemoresistance of pancreatic cancer by regulating SIRT1 and c-myc
-
Liu, Y, Li, X, Zhu, S, Zhang, JG, Yang, M, Qin, Q et al. (2015). Ectopic expression of miR-494 inhibited the proliferation, invasion and chemoresistance of pancreatic cancer by regulating SIRT1 and c-Myc. Gene Ther 22: 729-738.
-
(2015)
Gene Ther
, vol.22
, pp. 729-738
-
-
Liu, Y.1
Li, X.2
Zhu, S.3
Zhang, J.G.4
Yang, M.5
Qin, Q.6
-
28
-
-
84938149957
-
Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells
-
Tréhoux, S, Lahdaoui, F, Delpu, Y, Renaud, F, Leteurtre, E, Torrisani, J et al. (2015). Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells. Biochim Biophys Acta 1853(10 Pt A): 2392-2403.
-
(2015)
Biochim Biophys Acta
, vol.1853
, Issue.10
, pp. 2392-2403
-
-
Tréhoux, S.1
Lahdaoui, F.2
Delpu, Y.3
Renaud, F.4
Leteurtre, E.5
Torrisani, J.6
-
29
-
-
84991922343
-
Systemic delivery of microRNA-101 potently inhibits hepatocellular carcinoma in vivo by repressing multiple targets
-
Zheng, F, Liao, YJ, Cai, MY, Liu, TH, Chen, SP, Wu, PH et al. (2015). Systemic delivery of microRNA-101 potently inhibits hepatocellular carcinoma in vivo by repressing multiple targets. PLoS Genet 11: e1004873.
-
(2015)
PLoS Genet
, vol.11
-
-
Zheng, F.1
Liao, Y.J.2
Cai, M.Y.3
Liu, T.H.4
Chen, S.P.5
Wu, P.H.6
-
30
-
-
84885113592
-
Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy
-
Guzman-Aranguez, A, Loma, P and Pintor, J (2013). Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy. Br J Pharmacol 170: 730-747.
-
(2013)
Br J Pharmacol
, vol.170
, pp. 730-747
-
-
Guzman-Aranguez, A.1
Loma, P.2
Pintor, J.3
-
31
-
-
84987630012
-
Therapeutic antisense oligonucleotides against cancer: Hurdling to the clinic
-
Moreno, PM and Pêgo, AP (2014). Therapeutic antisense oligonucleotides against cancer: hurdling to the clinic. Front Chem 2: 87.
-
(2014)
Front Chem
, vol.2
, pp. 87
-
-
Moreno, P.M.1
Pêgo, A.P.2
-
32
-
-
84878368094
-
Biological activity and biotechnological aspects of locked nucleic acids
-
Lundin, KE, Højland, T, Hansen, BR, Persson, R, Bramsen, JB, Kjems, J et al. (2013). Biological activity and biotechnological aspects of locked nucleic acids. Adv Genet 82: 47-107.
-
(2013)
Adv Genet
, vol.82
, pp. 47-107
-
-
Lundin, K.E.1
Højland, T.2
Hansen, B.R.3
Persson, R.4
Bramsen, J.B.5
Kjems, J.6
-
33
-
-
84872432062
-
Clinical pharmacokinetics of second generation antisense oligonucleotides
-
Yu, RZ, Grundy, JS and Geary, RS (2013). Clinical pharmacokinetics of second generation antisense oligonucleotides. Expert Opin Drug Metab Toxicol 9: 169-182.
-
(2013)
Expert Opin Drug Metab Toxicol
, vol.9
, pp. 169-182
-
-
Yu, R.Z.1
Grundy, J.S.2
Geary, R.S.3
-
34
-
-
42249093319
-
LNA-mediated microRNA silencing in non-human primates
-
Elmén, J, Lindow, M, Schütz, S, Lawrence, M, Petri, A, Obad, S et al. (2008). LNA-mediated microRNA silencing in non-human primates. Nature 452: 896-899.
-
(2008)
Nature
, vol.452
, pp. 896-899
-
-
Elmén, J.1
Lindow, M.2
Schütz, S.3
Lawrence, M.4
Petri, A.5
Obad, S.6
-
35
-
-
78649877710
-
Short locked nucleic acid antisense oligonucleotides potently reduce apolipoprotein B mRNA and serum cholesterol in mice and non-human primates
-
Straarup, EM, Fisker, N, Hedtjärn, M, Lindholm, MW, Rosenbohm, C, Aarup, V et al. (2010). Short locked nucleic acid antisense oligonucleotides potently reduce apolipoprotein B mRNA and serum cholesterol in mice and non-human primates. Nucleic Acids Res 38: 7100-7111.
-
(2010)
Nucleic Acids Res
, vol.38
, pp. 7100-7111
-
-
Straarup, E.M.1
Fisker, N.2
Hedtjärn, M.3
Lindholm, M.W.4
Rosenbohm, C.5
Aarup, V.6
-
36
-
-
74249112787
-
Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection
-
Lanford, RE, Hildebrandt-Eriksen, ES, Petri, A, Persson, R, Lindow, M, Munk, ME et al. (2010). Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327: 198-201.
-
(2010)
Science
, vol.327
, pp. 198-201
-
-
Lanford, R.E.1
Hildebrandt-Eriksen, E.S.2
Petri, A.3
Persson, R.4
Lindow, M.5
Munk, M.E.6
-
37
-
-
54049085042
-
SPC3042: A proapoptotic survivin inhibitor
-
Hansen, JB, Fisker, N, Westergaard, M, Kjaerulff, LS, Hansen, HF, Thrue, CA et al. (2008). SPC3042: a proapoptotic survivin inhibitor. Mol Cancer Ther 7: 2736-2745.
-
(2008)
Mol Cancer Ther
, vol.7
, pp. 2736-2745
-
-
Hansen, J.B.1
Fisker, N.2
Westergaard, M.3
Kjaerulff, L.S.4
Hansen, H.F.5
Thrue, C.A.6
-
38
-
-
79953202455
-
Silencing of microRNA families by seed-targeting tiny LNAs
-
Obad, S, dos Santos, CO, Petri, A, Heidenblad, M, Broom, O, Ruse, C et al. (2011). Silencing of microRNA families by seed-targeting tiny LNAs. Nat Genet 43: 371-378.
-
(2011)
Nat Genet
, vol.43
, pp. 371-378
-
-
Obad, S.1
Dos Santos, C.O.2
Petri, A.3
Heidenblad, M.4
Broom, O.5
Ruse, C.6
-
39
-
-
84887841103
-
First-in-human phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer
-
Bianchini, D, Omlin, A, Pezaro, C, Lorente, D, Ferraldeschi, R, Mukherji, D et al. (2013). First-in-human phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer. Br J Cancer 109: 2579-2586.
-
(2013)
Br J Cancer
, vol.109
, pp. 2579-2586
-
-
Bianchini, D.1
Omlin, A.2
Pezaro, C.3
Lorente, D.4
Ferraldeschi, R.5
Mukherji, D.6
-
40
-
-
84877258007
-
Treatment of HCV infection by targeting microRNA
-
Janssen, HL, Reesink, HW, Lawitz, EJ, Zeuzem, S, Rodriguez-Torres, M, Patel, K et al. (2013). Treatment of HCV infection by targeting microRNA. N Engl J Med 368: 1685-1694.
-
(2013)
N Engl J Med
, vol.368
, pp. 1685-1694
-
-
Janssen, H.L.1
Reesink, H.W.2
Lawitz, E.J.3
Zeuzem, S.4
Rodriguez-Torres, M.5
Patel, K.6
-
41
-
-
79953075257
-
Bioanalytical LC-MS of therapeutic oligonucleotides
-
van Dongen, WD and Niessen, WM (2011). Bioanalytical LC-MS of therapeutic oligonucleotides. Bioanalysis 3: 541-564.
-
(2011)
Bioanalysis
, vol.3
, pp. 541-564
-
-
Van Dongen, W.D.1
Niessen, W.M.2
-
42
-
-
33847338002
-
Cross-species pharmacokinetic comparison from mouse to man of a second-generation antisense oligonucleotide, ISIS 301012, targeting human apolipoprotein B-100
-
Yu, RZ, Kim, TW, Hong, A, Watanabe, TA, Gaus, HJ and Geary, RS (2007). Cross-species pharmacokinetic comparison from mouse to man of a second-generation antisense oligonucleotide, ISIS 301012, targeting human apolipoprotein B-100. Drug Metab Dispos 35: 460-468.
-
(2007)
Drug Metab Dispos
, vol.35
, pp. 460-468
-
-
Yu, R.Z.1
Kim, T.W.2
Hong, A.3
Watanabe, T.A.4
Gaus, H.J.5
Geary, R.S.6
-
43
-
-
79959479529
-
Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes
-
Koller, E, Vincent, TM, Chappell, A, De, S, Manoharan, M and Bennett, CF (2011). Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes. Nucleic Acids Res 39: 4795-4807.
-
(2011)
Nucleic Acids Res
, vol.39
, pp. 4795-4807
-
-
Koller, E.1
Vincent, T.M.2
Chappell, A.3
De, S.4
Manoharan, M.5
Bennett, C.F.6
-
44
-
-
0035043324
-
Pharmacokinetics of phosphorothioate antisense oligodeoxynucleotides
-
Geary, RS, Yu, RZ and Levin, AA (2001). Pharmacokinetics of phosphorothioate antisense oligodeoxynucleotides. Curr Opin Investig Drugs 2: 562-573.
-
(2001)
Curr Opin Investig Drugs
, vol.2
, pp. 562-573
-
-
Geary, R.S.1
Yu, R.Z.2
Levin, A.A.3
-
45
-
-
84858020530
-
Peripheral administration of antisense oligonucleotides targeting the amyloid-β protein precursor reverses AβPP and LRP-1 overexpression in the aged SAMP8 mouse brain
-
Erickson, MA, Niehoff, ML, Farr, SA, Morley, JE, Dillman, LA, Lynch, KM et al. (2012). Peripheral administration of antisense oligonucleotides targeting the amyloid-β protein precursor reverses AβPP and LRP-1 overexpression in the aged SAMP8 mouse brain. J Alzheimers Dis 28: 951-960.
-
(2012)
J Alzheimers Dis
, vol.28
, pp. 951-960
-
-
Erickson, M.A.1
Niehoff, M.L.2
Farr, S.A.3
Morley, J.E.4
Dillman, L.A.5
Lynch, K.M.6
-
46
-
-
80054760122
-
Measurement of phosphorothioate oligodeoxynucleotide antisense transport across the blood-brain barrier
-
Banks, WA (2011). Measurement of phosphorothioate oligodeoxynucleotide antisense transport across the blood-brain barrier. Methods Mol Biol 789: 337-342.
-
(2011)
Methods Mol Biol
, vol.789
, pp. 337-342
-
-
Banks, W.A.1
-
47
-
-
0035015218
-
Delivery across the blood-brain barrier of antisense directed against amyloid beta: Reversal of learning and memory deficits in mice overexpressing amyloid precursor protein
-
Banks, WA, Farr, SA, Butt, W, Kumar, VB, Franko, MW and Morley, JE (2001). Delivery across the blood-brain barrier of antisense directed against amyloid beta: reversal of learning and memory deficits in mice overexpressing amyloid precursor protein. J Pharmacol Exp Ther 297: 1113-1121.
-
(2001)
J Pharmacol Exp Ther
, vol.297
, pp. 1113-1121
-
-
Banks, W.A.1
Farr, S.A.2
Butt, W.3
Kumar, V.B.4
Franko, M.W.5
Morley, J.E.6
-
48
-
-
84937252483
-
Antisense oligonucleotides in therapy for neurodegenerative disorders
-
Evers, MM, Toonen, LJ and van Roon-Mom, WM (2015). Antisense oligonucleotides in therapy for neurodegenerative disorders. Adv Drug Deliv Rev 87: 90-103.
-
(2015)
Adv Drug Deliv Rev
, vol.87
, pp. 90-103
-
-
Evers, M.M.1
Toonen, L.J.2
Van Roon-Mom, W.M.3
-
49
-
-
0028241377
-
Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate
-
Sands, H, Gorey-Feret, LJ, Cocuzza, AJ, Hobbs, FW, Chidester, D and Trainor, GL (1994). Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate. Mol Pharmacol 45: 932-943.
-
(1994)
Mol Pharmacol
, vol.45
, pp. 932-943
-
-
Sands, H.1
Gorey-Feret, L.J.2
Cocuzza, A.J.3
Hobbs, F.W.4
Chidester, D.5
Trainor, G.L.6
-
50
-
-
84856431819
-
RNA therapeutics: Beyond RNA interference and antisense oligonucleotides
-
Kole, R, Krainer, AR and Altman, S (2012). RNA therapeutics: beyond RNA interference and antisense oligonucleotides. Nat Rev Drug Discov 11: 125-140.
-
(2012)
Nat Rev Drug Discov
, vol.11
, pp. 125-140
-
-
Kole, R.1
Krainer, A.R.2
Altman, S.3
-
51
-
-
78349312100
-
Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes
-
Jørgensen, S, Baker, A, Møller, S and Nielsen, BS (2010). Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes. Methods 52: 375-381.
-
(2010)
Methods
, vol.52
, pp. 375-381
-
-
Jørgensen, S.1
Baker, A.2
Møller, S.3
Nielsen, B.S.4
-
52
-
-
79951671912
-
High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients
-
Nielsen, BS, Jørgensen, S, Fog, JU, Søkilde, R, Christensen, IJ, Hansen, U et al. (2011). High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clin Exp Metastasis 28: 27-38.
-
(2011)
Clin Exp Metastasis
, vol.28
, pp. 27-38
-
-
Nielsen, B.S.1
Jørgensen, S.2
Fog, J.U.3
Søkilde, R.4
Christensen, I.J.5
Hansen, U.6
-
53
-
-
84921825723
-
Chromogen detection of microRNA in frozen clinical tissue samples using LNA" probe technology
-
Nielsen, BS, Møller, T and Holmstrøm, K (2014). Chromogen detection of microRNA in frozen clinical tissue samples using LNA" probe technology. Methods Mol Biol 1211: 77-84.
-
(2014)
Methods Mol Biol
, vol.1211
, pp. 77-84
-
-
Nielsen, B.S.1
Møller, T.2
Holmstrøm, K.3
|